AbbVie Inc. (ETR:4AB)
163.40
-0.80 (-0.49%)
Jul 18, 2025, 5:35 PM CET
AbbVie Revenue
AbbVie had revenue of $13.34B USD in the quarter ending March 31, 2025, with 8.39% growth. This brings the company's revenue in the last twelve months to $57.37B, up 5.45% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$57.37B
Revenue Growth
+5.45%
P/S Ratio
5.40
Revenue / Employee
$1.04M
Employees
55,000
Market Cap
286.84B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.17B |
AbbVie News
- 1 day ago - July's 5 Dividend Growth Stocks With Yields Up To 7.96% - Seeking Alpha
- 2 days ago - Why AbbVie Is a Strong Buy for Long-Term Investors in 2025 - FX Empire
- 2 days ago - AbbVie: Why I Set A $175 Buy Order - Seeking Alpha
- 3 days ago - Nomura remains neutral on Glenmark, says near-term upside for stock captured post ISB-2001 deal - Business Upturn
- 3 days ago - My Top 2 Earnings Picks For This Earnings Season - Benzinga
- 4 days ago - Yesterday' Stock Market: What You Must Know! - Forexlive
- 5 days ago - Tech drives gains: NVDA and AMD lead the charge while healthcare faces setbacks - Forexlive
- 6 days ago - HSBC raises Glenmark Pharma share price target to Rs 2,275 on $1.9 billion AbbVie licensing deal - Business Upturn